Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Review role of topotecan in gynaecological cancers: Current indications and perspectives
Critical Reviews in Oncology/Hematology, 09/25/09
Lorusso D et al. – The aim of this article is to review the role of topotecan (Hycamtin), a semi–synthetic alkaloid derivative of camptothecin, in ovarian and cervical cancer in monotherapy and in combination. Topotecan (Hycamtin) will continue to play a role in the treatment of advanced ovarian and cervical cancer, in monotherapy or in combination with other cytotoxic agents.
Related Articles
Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3 mediated Bid cleavage
Journal of Pharmacology and Experimental Therapeutics, 10/14/09
Relevance Score: 82%
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia
Cancer, 11/06/09
Relevance Score: 80%
Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: Pharmacological rationale and clinical response
Pediatric Blood & Cancer, 10/27/09
Relevance Score: 80%
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: childrens oncology group study d9803
Journal of Clinical Oncology, 10/08/09
Relevance Score: 80%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma
The Journal of Pathology, 12/11/09
Validation of EQ-5D in patients with cervical cancer in Taiwan
Supportive Care in Cancer, 12/11/09
Association of BRCA1 mutations with occult primary ovarian insufficiency: A possible explanation for the link between infertility and breast/ovarian cancer risks
Journal of Clinical Oncology, 12/11/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
Clinical Cancer Research, 12/11/09
Radiation Therapy for Rectal Cancer: Current Status and Future Directions
Cancer Control, 12/11/09
Current Progress in Targeted Therapy for Colorectal Cancer
Cancer Control, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


